Patients were then randomized to receive an intravenous infusion of either 15 µg/kg salbutamol ... Conclusion: A single-dose intravenous salbutamol bolus of 15 µg/kg administered over 10 mins ...

The bolus is delivered using the bolus dose feature with a smart infusion pump that allows programming of both the bolus dose and continuous infusion rate, and then automatically switches to the ...

Recent study investigates the differences in anatomical dye distribution patterns and nerve blockade effectiveness between ...

SP-26 implants are designed to deliver ketamine at a controlled rate, avoiding the dissociative effects associated with IV bolus injection and providing a viable alternative to highly addictive opioid ...

avoiding the dissociative effects associated with IV bolus injection and providing a viable alternative to highly addictive opioid treatments. "SP-26 has been designed to offer a new approach to ...

SP-26 implants are designed to deliver ketamine at a controlled rate, avoiding the dissociative effects associated with IV bolus injection and providing a viable alternative to highly addictive ...

Yelena Y. Janjigian, MD, discusses how to manage the potential adverse events of pembrolizumab when using the recently ...

Some pumps also offer an “extended bolus” option ... You should change the infusion site of your pump every 2 to 4 days even if the insulin lasts longer, because the site may begin to break ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

In a wide-ranging interview, he explains his decision — amid the Trump administration’s assault on foreign aid — to accelerate the end of his giving. Credit...Katy Grannan for The New York ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. Our lead indication for 4D-150 is wet age-related macular degeneration, which is ...